Keywords: Zoledronic acid, Early lung cancer, Novartis, Reclast

Bone drug zoledronic acid may help prevent spread of early lung cancer

Article | 02 March 2011

Print This

Zoledronic acid, a drug that is currently used to help treat bone metastases in patients with lung cancer could also ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in